Thrombocytopenic purpura
MONDO:0043768Purpura associated with a reduction in circulating blood platelets which can result from a variety of factors.
Also known as: thrombocytopenic purpura, purpura, thrombopenic, purpuras, thrombocytopenic, purpuras, thrombopenic, thrombocytopenic purpuras, thrombopenic purpura, thrombopenic purpuras
128 clinical trials for this condition and its sub-types, 8 tagged with Thrombocytopenic purpura itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Thrombocytopenic purpura
-
Autoimmune thrombocytopenic purpura 95 trials
-
Thrombotic thrombocytopenic purpura 15 trials · 20 incl. sub-types
2 sub-types
-
New injection aims to stabilize platelets in chronic ITP patients
Disease control Recruiting nowThis Phase 3 trial tests whether mezagitamab, given as a shot under the skin, can safely keep platelet counts stable in adults with chronic ITP. ITP is a condition where the immune system destroys platelets, leading to easy bruising and bleeding. The study will compare mezagitama…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New shot shows promise for Long-Term control of bleeding disorder
Disease control Recruiting nowThis study tests the long-term safety of a drug called mezagitamab for adults with chronic immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing easy bruising and bleeding. About 150 participants who completed earlier mezagitamab studies w…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for ITP patients: weekly shot may boost platelets when pills Don't work
Disease control Recruiting nowThis study tests a weekly injection called romiplostim in 60 adults with immune thrombocytopenia (ITP) whose platelet counts stayed low despite oral medications. The goal is to see if the shot can safely raise platelet levels and reduce bleeding over 24 weeks. Participants stop t…
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC